Bernstein Karen 4
4 · Ovid Therapeutics Inc. · Filed Jun 8, 2020
Insider Transaction Report
Form 4
Bernstein Karen
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-06-05+13,250→ 13,250 totalExercise: $5.29Exp: 2030-06-04→ Common Stock (13,250 underlying)
Footnotes (1)
- [F1]The option will vest in full on June 5, 2021, subject to the Reporting Person's continuous service through such vesting date.